Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2169-2026

QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp. Recall

QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.

FDA recall Class II

Ongoing

FDA lists this Class II recall for QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2169-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 6, 2026
FDA report date
May 20, 2026
Quantity in commerce
12279 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.

Affected model & UDI checker

Search the exact identifiers published for Z-2169-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
20108QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.Check source noticeNot specified
Not specifiedQuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.Check source notice30014613201083
FDA code information

UDI/DI 30014613201083, Lot Numbers: 225788, 228322, 233274.

View the original FDA recall notice

Why was this product recalled?

Product has the potential for false positive results

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Quidel Corporation take?

QuidelOrtho issued an URGENT PRODUCT CORRECTION NOTIFICATION to its consignees on 4/6/2026 via courier (FedEx). The notice explained the problem, impact to results, and requested the following: "REQUIRED ACTION " Discontinue using, render unusable, and discard your remaining inventory of the above listed lots of QuickVue Dipstick Strep A Test. " Review the content of this communication with your Medical Director and retain this letter for your laboratory. " Complete and return the enclosed Confirmation of Receipt form no later than April 13, 2026. Upon receipt of your completed Confirmation of Receipt form, QuidelOrtho will credit or replace your discarded inventory, as needed. " Please forward this notification if the affected product was distributed outside of your facility." For questions, contact: Technical Support team at 1-800-874-1517 or technicalsupport@quidelortho.com. Distributors were requested to perform the following: "REQUIRED ACTION " Send the enclosed Customer Letter and Confirmation of Receipt form to all customers who have been shipped the affected lots of QuickVue" Dipstick Strep A Test from your facility. " Complete and return the enclosed Distributor Confirmation of Receipt form no later than April 13, 2026. " Please forward this notification if the affected product was distributed outside of your facility."

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology